Lucy Lu
2021 - AVENUE THERAPEUTICS
In 2021, Lucy Lu earned a total compensation of $1.1M as Chief Executive Officer at AVENUE THERAPEUTICS, a 144% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,079 |
|---|---|
| Salary | $454,647 |
| Stock Awards | $382,803 |
| Other | $11,600 |
| Total | $1,082,129 |
Lu received $454.6K in salary, accounting for 42% of the total pay in 2021.
Lu also received $233.1K in non-equity incentive plan, $382.8K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Lucy Lu's compensation ranked 8,521st out of 12,406 executives tracked by ExecPay. In other words, Lu earned more than 31.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,521 out of 12,406 | 31st |
Division Manufacturing | 3,775 out of 5,492 | 31st |
Major group Chemicals And Allied Products | 1,672 out of 2,368 | 29th |
Industry group Drugs | 1,489 out of 2,089 | 29th |
Industry Pharmaceutical Preparations | 1,108 out of 1,536 | 28th |
Source: SEC filing on November 18, 2022.
Lu's colleagues
We found one more compensation record of an executive who worked with Lucy Lu at AVENUE THERAPEUTICS in 2021.
2021
Joseph Vazzano
AVENUE THERAPEUTICS
Chief Financial Officer
News
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019